Prevalence of fabry disease in stroke patients - A systematic review and meta-analysis

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 5, 2014, Pages 985-992

  Shi, Qiyun ^a,b   Chen, Junji ^c   Pongmoragot, Jitphapa ^b   Lanthier, Sylvain ^d   Saposnik, Gustavo ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Fabry disease; meta analysis; prevalence; stroke; youth

Indexed keywords

ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; EARLY DIAGNOSIS; FABRY DISEASE; GENDER; HUMAN; INCIDENCE; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; STROKE PATIENT; SYSTEMATIC REVIEW; ENZYME REPLACEMENT; FEMALE; MALE; RISK ASSESSMENT; RISK FACTOR; STROKE;

ENZYME REPLACEMENT THERAPY; FABRY DISEASE; FEMALE; HUMANS; MALE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 84901295382     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.08.010     Document Type: Article

References (46)

1. R.O. Brady, A.E. Gal, and R.M. Bradley et al. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency N Engl J Med 276 1967 1163
2. J. Kint Fabry's disease: alpha-galactosidase deficiency Science (New York, NY) 167 1970 1268
3. P. Kotanko, R. Kramar, and D. Devrnja et al. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients J Am Soc Nephrol 15 2004 1323 1329
4. A. Linhart, S. Magage, and T. Palecek et al. Cardiac involvement in Fabry disease Acta Paediatr Suppl 91 2002 15 20
5. A. Rolfs, T. Bottcher, and M. Zschiesche et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study Lancet 366 2005 1794 1796
6. Y.A. Zarate, L. Patterson, and H. Yin et al. A case of minimal change disease in a Fabry patient Pediatr Nephrol 25 2010 553 556
7. M.A. Barba-Romero, A. Rivera-Gallego, and G. Pintos-Morell Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS) Int J Clin Pract 65 2011 903 910
8. M. Elleder, V. Bradova, and F. Smid et al. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease Virchows Archiv 417 1990 449 455
9. S. Nakao, C. Kodama, and T. Takenaka et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype Kidney Int 64 2003 801 807
10. Y.A. Zarate, and R.J. Hopkin Fabry's disease Lancet 372 2008 1427 1435
11. G.E. Linthorst, M.G. Bouwman, and F.A. Wijburg et al. Screening for Fabry disease in high-risk populations: a systematic review J Med Genet 47 2010 217 222
12. R. Brouns, R. Sheorajpanday, and E. Braxel et al. Middelheim Fabry Study (MIFAS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke Clin Neurol Neurosurg 109 2007 479 484
13. M.V. Baptista, S. Ferreira, and T. Pinho-e-Melo et al. Mutations of the GLA gene in young patients with stroke the PORTYSTROKE study - screening genetic conditions in Portuguese young stroke patients Stroke 41 2010 431 436
14. R. Brouns, V. Thijs, and F. Eyskens et al. Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease Stroke 41 2010 863 868
15. V. Dubuc, D.F. Moore, and L.C. Gioia et al. Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke J Stroke Cerebrovasc Dis 22 2013 1288 1292
16. A. Rolfs, F. Fazekas, and U. Grittner et al. Acute cerebrovascular disease in the young: the stroke in young Fabry patients study Stroke 44 2013 340 349
17. H. Sarikaya, M. Yilmaz, and N. Michael et al. Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA Eur J Neurol 19 2012 1421 1426
18. M.A. Wozniak, S.J. Kittner, and S. Tuhrim et al. Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke Stroke 41 2010 78 81
19. G. Saposnik, S. Lanthier, and M. Mamdani et al. Fabry's disease: a prospective multicenter cohort study in young adults with cryptogenic stroke Int J Stroke 7 2012 265 273
20. M.H. Boyle Guidelines for evaluating prevalence studies Evid Based Ment Health 1 1998 37 39
21. P.F. Whiting, A. Rutjes, and M.E. Westwood et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Ann Int Med 155 2011 529
22. J.P.T. Higgins, S. Green, and C. Collaboration Cochrane handbook for systematic reviews of interventions 2008 Wiley Online Library
23. L. Marquardt, R. Baker, and H. Segal et al. Fabry disease in unselected patients with TIA or stroke: population-based study Eur J Neurol 19 2012 1427 1432
24. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel iii) JAMA 285 2001 2486 2497
25. R.J. Valentine, R. Verstraete, and G.P. Clagett et al. Premature cardiovascular disease is common in relatives of patients with premature peripheral atherosclerosis Arch Intern Med 160 2000 1343 1348
26. A.S. Gami, S. Rader, and A. Svatikova et al. Familial premature coronary artery disease mortality and obstructive sleep apnea Chest 131 2007 118 121
27. G. Saposnik, D. Redelmeier, and H. Lu et al. Premature risk of stroke associated with recency of immigration to Ontario BMJ 2009 [under revision]
28. R.J. Desnick, and C.M. Eng Alpha galactosidase a deficiency: fabry disease C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, The metabolic and molecular bases of inherited disease 2001 McGraw-Hill New York 3733 3774
29. B.M. Kissela, J.C. Khoury, and K. Alwell et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population Neurology 79 2012 1781 1787
30. G.C. Fonarow, M.J. Reeves, and X. Zhao et al. Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke Circulation 121 2010 879 891
31. G. Saposnik, R. Cote, and S. Phillips et al. Stroke outcome in those over 80: a multicenter cohort study across canada Stroke 39 2008 2310 2317
32. D. Griffiths, and J. Sturm Epidemiology and etiology of young stroke Stroke Res Treat 2011 2011 209370
33. H.P. Adams Jr., G. del Zoppo, and M.J. Alberts et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Circulation 115 2007 e478 e534
34. J.G. Morris, E.J. Duffis, and M. Fisher Cardiac workup of ischemic stroke: can we improve our diagnostic yield? Stroke 40 2009 2893 2898
35. P. Gaspar, J. Herrera, and D. Rodrigues et al. Frequency of Fabry disease in male and female haemodialysis patients in Spain BMC Med Genet 11 2010 19
36. L. Monserrat, J.R. Gimeno-Blanes, and F. Marin et al. Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy J Am College Cardiol 50 2007 2399 2403
37. G.M. Pastores, and Y.H. Lien Biochemical and molecular genetic basis of Fabry disease J Am Soc Nephrol 13 Suppl 2 2002 S130 S133
38. E. Schafer, K. Baron, and U. Widmer et al. Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease Hum Mutat 25 2005 412
39. K.L. Furie, S.E. Kasner, and R.J. Adams et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 227 276
40. R.O. Brady, G.J. Murray, and D.F. Moore et al. Enzyme replacement therapy in Fabry disease J Inherit Metab Disease 24 Suppl 2 2001 18 24 discussion 11-12
41. M. Dutsch, H. Marthol, and B. Stemper et al. Small fiber dysfunction predominates in Fabry neuropathy J Clin Neurophysiol 19 2002 575 586
42. G.E. Linthorst, C.E. Hollak, and W.E. Donker-Koopman et al. Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta Kidney Int 66 2004 1589 1595
43. R. Schiffmann, G.J. Murray, and D. Treco et al. Infusion of alpha-galactosidase a reduces tissue globotriaosylceramide storage in patients with Fabry disease Proc Natl Acad Sci USA 97 2000 365 370
44. M. Banikazemi, J. Bultas, and S. Waldek et al. Agalsidase-beta therapy for advanced Fabry disease: a randomized trial Ann Internal Med 146 2007 77 86
45. F. Weidemann, M. Niemann, and S. Stork et al. Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications J Int Med 274 2013 331 341
46. W.R. Wilcox, M. Banikazemi, and N. Guffon et al. Long-term safety and efficacy of enzyme replacement therapy for Fabry disease Am J Hum Genet 75 2004 65